Literature DB >> 1766495

Evaluation of platelets and hemostasis during hemodialysis with six different membranes.

D Verbeelen1, K Jochmans, A G Herman, P Van der Niepen, J Sennesael, M De Waele.   

Abstract

Hemodialysis induces thrombocytopenia and activation of coagulation. The severity of this reaction depends on the kind of membrane. In this study, we present the results of determination of platelet count, and of different factors of coagulation in 10 stable dialysis patients. Measurements were performed at the start and after 15 and 45 min of dialysis. Samples were taken before and after the dialyzer. All 10 patients were treated consecutively and in a random order during 14 days with the following membranes: polyacrylonitrile (Filtral 12, Hospal), hemophan (GFS 120 Plus, Gambro, and Bio-Nephros HF Andante, Organon), polysulfone (F6, Fresenius), cuprammonium (AM50-BIO, Asahi) and cellulose acetate (Duo-Flux, Cordis-Dow). The cellulose acetate membrane induced a small but significant drop of mean platelet count [results are mean (SEM)]: from 245,000 (17,000) to 224,000 (16,000)/microliters after 15 min. With the same membrane a dramatic increase after 15 min was noted of 6-keto-PGF1 alpha from 56.3 (9) to 146.7 (35.7) pg/ml. The other membranes did not influence significantly prostanoid levels and platelet count. During dialysis no significant changes of fibrinopeptide A (FPA) and von Willebrand factor (VWF) were observed. Nevertheless, predialysis FPA and beta-thromboglobulin (beta TG) concentrations were lowest after 14 days of treatment with cellulose acetate and polyacrylonitrile membranes. It is concluded that the activation of coagulation depends on the membrane used. The activation may be dominated by one single system (e.g. prostanoids). The different predialysis concentration of some of the factors suggests interference of the dialysis membrane with the activation of coagulation during the interdialytic period.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1766495     DOI: 10.1159/000186645

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  8 in total

Review 1.  What are the anticoagulation options for intermittent hemodialysis?

Authors:  Andrew Davenport
Journal:  Nat Rev Nephrol       Date:  2011-07-05       Impact factor: 28.314

Review 2.  High-flux versus low-flux membranes for end-stage kidney disease.

Authors:  Suetonia C Palmer; Kannaiyan S Rabindranath; Jonathan C Craig; Paul J Roderick; Francesco Locatelli; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

3.  The clinical diagnosis of heparin-induced thrombocytopenia in patients receiving continuous renal replacement therapy.

Authors:  Chris E Holmes; Joe C Huang; Carina Cartelli; Alan Howard; Jeffrey Rimmer; Mary Cushman
Journal:  J Thromb Thrombolysis       Date:  2008-05-17       Impact factor: 2.300

Review 4.  Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.

Authors:  A M Macleod; M Campbell; J D Cody; C Daly; C Donaldson; A Grant; I Khan; K S Rabindranath; L Vale; S Wallace
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

5.  Comparative analysis of the long-term effect of two families of high-flux polysulfone dialysers on platelet count: a retrospective cross-sectional study.

Authors:  Rosaria Del Giorno; Lorenzo Berwert; Silvio Pianca; Giorgia Bianchi; Olivier Giannini; Luca Gabutti
Journal:  Ther Clin Risk Manag       Date:  2017-10-16       Impact factor: 2.423

6.  Thrombocytopenia in the setting of hemodialysis using biocompatible membranes.

Authors:  Kathryn B Muir; Clifford D Packer
Journal:  Case Rep Med       Date:  2012-10-09

7.  Relationship between platelet count and hemodialysis membranes.

Authors:  Rabih Nasr; Chadi Saifan; Iskandar Barakat; Yorg Al Azzi; Ali Naboush; Marc Saad; Suzanne El Sayegh
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-08-14

8.  Hemodialysis Does Not Induce Detectable Activation of the Contact System of Coagulation.

Authors:  Karlien François; Christelle Orlando; Kristin Jochmans; Wilfried Cools; Vicky De Meyer; Christian Tielemans; Karl Martin Wissing
Journal:  Kidney Int Rep       Date:  2020-03-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.